相关实验视频
Updated: May 12, 2025

07:04
Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology
Published on: May 2, 2025
155
最近在PD-L1 siRNA纳米载体中取得的进展,用于癌症治疗
Sristi1, Garima Gupta2, Mohammed A S Abourehab3
1Department of Pharmaceutics, Amity Institute of Pharmacy, Amity University, Sector 125, Noida 201301, UP, India.
概括
纳米载体增强了小干扰RNA (siRNA) 的传递,准编程死亡配体1 (PD-L1),以改善癌症免疫疗法. 这种方法可以增强抗瘤免疫力,并与其他疗法相结合时显示出潜力.
科学领域:
- 在瘤学瘤学.
- 纳米技术纳米技术
- 免疫治疗是一种免疫疗法.
背景情况:
- 瘤免疫逃避是由被编程的死亡连接体1 (PD-L1) 介导的.
- 针对PD-L1的小干扰RNA (siRNA) 提供了一个新的癌症治疗策略.
- siRNA在稳定性和治疗用途的细胞传递方面面临挑战.
研究的目的:
- 审查纳米载体系统,用于在癌症治疗中传递PD-L1siRNA.
- 探索用于PD-L1向的纳米载体的设计创新和应用.
- 讨论PD-L1siRNA纳米载体的协同效应和挑战.
主要方法:
- 对纳米载体技术 (脂质,聚合物,无机) 的全面审查.
- 在各种癌症模型中分析纳米载体应用.
- 对化疗和免疫调节剂的协同效应的评估.
主要成果:
- 纳米载体提高了PD-L1siRNA的稳定性和细胞传递.
- 各种纳米载体系统在准PD-L1.1方面表现出有效性.
- 与联合疗法观察到的协同效应增强了抗瘤反应.
结论:
- 通过纳米载体传递的PD-L1 siRNA在癌症免疫治疗中显示出显著的潜力.
- 纳米载体技术克服了siRNA疗法的关键局限性.
- 需要进一步的研究来优化生物分布,并最大限度地减少临床翻译的非目标效应.
相关概念视频
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
siRNA - Small Interfering RNAs
16.3K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.3K

